Related Experiment Video
Updated: Jan 27, 2026
26:41
Perspectives on Neuroscience
Published on: July 31, 2007
5.3K
Pediatric drug regulation: International perspectives
Victor C Baum1, Ralph Bax2, Dominique Heon3
1Departments of Anesthesiology & Critical Care Medicine and Pediatrics, George Washington University, Washington, District of Columbia.
Paediatric Anaesthesia
|March 30, 2019
Summary
Protecting children through research is now standard practice, evolving from past exclusion. Governments incentivize pediatric drug studies and international cooperation aids regulatory harmonization.
Area of Science:
- Pediatric pharmacology
- Drug regulation
- International health policy
Background:
- Historically, children were excluded from drug research to protect them.
- Current approaches prioritize protecting children *through* ethical research.
- Regulatory frameworks have evolved to mandate and incentivize pediatric drug studies.
Observation:
- Governments offer financial incentives and impose requirements on pharmaceutical companies for pediatric drug development.
- International collaboration involves patient representatives, regulatory agencies, and industry stakeholders.
- Unique considerations for pediatric drug safety and efficacy are recognized globally.
Findings:
- Pediatric drug regulation has been examined across five major international regulatory agencies.
- The study details the evolution of pediatric drug research and regulation.
- International cooperation efforts in pediatric drug regulation are discussed.
Implications:
- Harmonized international pediatric drug regulations can accelerate the availability of safe and effective medicines for children.
- Continued collaboration is crucial for addressing the specific needs of pediatric populations in drug development.
- This research informs future policy and practice in pediatric drug approval worldwide.
Keywords:
Chinese National Drug AdministrationEU Paediatric RegulationEuropean Medicines AgencyFood and Drug AdministrationHealth CanadaPharmaceuticals and Medical Devices Agencypediatric drug regulationMore Related Videos
Related Concept Videos
01:25Drug Regulation
2.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
203
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
262
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
02:00Internal Energy
36.6K
The total of all possible kinds of energy present in a substance is called the internal energy (U), sometimes symbolized as E. Suppose a system with initial internal energy, Uinitial, undergoes a change in energy (transfer of work or heat), and the final internal energy of the system is Ufinal. Change in internal energy equals the difference between Ufinal and Uinitial.
36.6K